## Abstract ## Background and Objectives Expression of a panel of biomarkers, such as p53, Bcl‐2, Cyclin D1, c‐__myc__, p21ras, c‐erb B2, cytokeratin‐19 (CK‐19), and factor VIII–related antigen (FVIII‐RA), was studied together in anterior tongue tumors from the oral cavity and in posterior tongue
Univariate and multivariate analysis of prognostic significance of betel quid chewing in squamous cell carcinoma of buccal mucosa in Taiwan
✍ Scribed by Jang-Jaer Lee; Jiiang-Huei Jeng; Hsiao-Mei Wang; Hao-Hueng Chang; Chun-Pin Chiang; Ying-Shiung Kuo; Wan-Hong Lan; Sang-Heng Kok
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 96 KB
- Volume
- 91
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background and Objectives
While betel quid (BQ) chewing is clearly the most avoidable risk factor of squamous cell carcinoma of buccal mucosa (BMSCC), little is known about the influence of this habit on the prognosis of BMSCC.
Methods
We surveyed 280 patients with BMSCC who were treated during an 8‐year period in a cohort study to assess the independent predictive value of pretreatment BQ chewing habit on the prognosis by univariate and multivariate analysis.
Results
We found by univariate analysis that sex, age, clinical stage, smoking, and BQ chewing significantly affected the patients' prognosis and only age, clinical stage, and BQ chewing had significant influence on prognosis by multivariate analysis (P < 0.05). Further analysis revealed that the prognostic effect of BQ chewing changed in a dose‐ and time‐dependent manner. The risk of death was 31.4‐fold higher in heavy user (duration >30 years, daily consumption >30 quids, age of start <20 years old) when compared to those who chewed BQ to a milder degree (duration <10 years, daily consumption <15 quids, age of start ≥20 years old ) (P < 0.001).
Conclusions
Pretreatment BQ chewing habit worsens the prognosis of BMSCC in Taiwan. BQ chewing is a prognostic indicator that can be used in conjunction with clinical staging to help plan the treatment for the patients. J. Surg. Oncol. 2005;91:41–47. © 2005 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract ## Background Multiple marker accumulation impacts tumor progression and biologic phenotypes affect clinical outcome of patients with head and neck cancer. Hence, this study investigated a battery of molecular markers that may help to reflect biologic aggressiveness and predict prognos